Brisbane Economic Development Agency (BEDA) has selected 11 businesses to join the second-year cohort of its successful MedTech Global Accelerator program, to fast track their connections with international partners for collaboration, investment, and distribution deals.
Lord Mayor Adrian Schrinner said Brisbane was a globally recognised leader in medical technology, powered by a vibrant start-up culture, world-class research and healthcare institutions and great local talent.
“Brisbane has a global reputation for developing life-changing health innovation and the continued success of homegrown start-ups around the world will drive economic growth, create new jobs and continue attracting leading talent to the city,” Cr Schrinner said.
“The calibre of businesses participating in the MedTech Accelerator program is testament to the quality of the research and development happening in Brisbane, with more than half of last year’s cohort already securing new partnerships, investment and clients.
“Brisbane’s world-class research and health institutes are incubators for ground-breaking innovations with the potential to improve patient outcomes, make healthcare faster and more convenient for people and even save lives.
“Council is proud to continue championing local business for global investment as we establish new market pathways through this program.”
Renowned Clinician-Entrepreneur Professor John Fraser is founder of Brisbane MedTech company and cohort alumni, De Motu Cordis, a needle-free epinephrine smart inhaler for the treatment of anaphylaxis, and founder of the Critical Care Research Group. Professor John Fraser joins the program as an official ambassador to spearhead Brisbane's global reputation for medical innovation.
“Brisbane’s success in biotech and health isn’t an overnight success story – it’s underpinned by the collective contribution of the city’s state of the art health institutes and universities, connected medical hospital network and top tier talent,” said Professor John Fraser.
“Brisbane is already seen as punching way above its weight in the MedTech industry and I’m honoured to fly the flag and help the city push even further ahead by amplifying Brisbane’s credentials as a leading destination for technology and innovation in the health sector.”
BEDA’s MedTech accelerator program is delivered in partnership with US based investment facilitator Life Science Nation and will culminate with attendance at the global investor RESI Conference in San Francisco where participants will pitch to active investors during JP Morgan Healthcare Week in January 2024.
Important Disclaimer: Selection for participation in the MedTech Accelerator Program (the Program) does not amount to any representation or endorsement, either direct or indirect, by Brisbane Economic Development Agency (BEDA) or any of its officers, employees or contractors, of any intellectual property, technology, product, service or offering provided or developed, or proposed to be provided or developed, by any participant in the Program. No participant in the Program, will, directly or indirectly, state or imply that participation in the Program is an endorsement by BEDA.